Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sanofi, BEYFORTUS
Sanofi begins shipping BEYFORTUS to US for RSV prevention in infants
French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US, targeting both private healthcare providers and the Centers for Disease Control and Prevention's Vaccines for Children programme,
Sanofi To Offer BEYFORTUS Doses To Protect Babies During RSV Season - Quick Facts
Sanofi (SNYNF, SNY) said it is shipping BEYFORTUS 50mg and 100mg Injection doses in the US to private healthcare providers and to the
Sanofi shipping RSV jab Beyfortus in USA
French pharma major Sanofi today revealed it is shipping Beyfortus (nirsevimab-alip) 50mg and 100mg Injection doses in the USA to private healthcare providers and to the Centers for Disease Control and Prevention.
Sanofi Shipping BEYFORTUS® In US To Help Protect Babies Against RSV Disease New Manufacturing Line Approved By FDA
Company planning for every eligible baby in the US to have access to BEYFORTUS <li /> New BEYFORTUS filling line approved by the
US FDA approves manufacturing line for Sanofi's preventive RSV therapy
Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca's preventive respiratory syncytial virus (RSV) therapy.
FiercePharma
5d
With amped up manufacturing effort, Sanofi and AZ look to avoid Beyfortus shortfalls this year
As this year’s respiratory syncytial virus (RSV) season approaches,
Beyfortus
makers Sanofi and AstraZeneca are making ...
TBR News Media
2d
Local doctors recommend flu and covid shots cosome time in the next few weeks
With the peak flu season often occurring during December and January and even into February, Dr. Sharon Nachman, Chief of the ...
Zacks.com on MSN
3d
Sanofi Stock Up Almost 23% in 3 Months: Buy, Sell or Hold?
Sanofi’s SNY stock has gained 22.7% in the past three months compared with an increase of 2.9% for the industry. The stock ...
4d
RSV Can Be a Killer. New Tools Are Identifying the Most At-Risk Kids
RSV infects almost every child before they turn 2, and kills more than 100,000 infants worldwide each year. Machine learning ...
The Canadian Press on MSN
3d
After years of advocacy by a pediatrician, all Nunavut babies to get RSV immunization
The Nunavut government says it will provide immunization against respiratory syncytial virus to all infants in the territory ...
Morningstar
6d
Sanofi shipping BEYFORTUS® in US to help protect babies against RSV disease; new manufacturing line approved by FDA
Company planning for every eligible baby in the US to have access to
BEYFORTUS
New
BEYFORTUS
filling line approved by the U.S. Food and Drug Administration (FDA) to expand manufacturing capacity ...
Jefferson Public Radio
2d
COVID-19, RSV, flu: Updated shots are available now in Oregon
October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.
2d
Sanofi: A Strong Buy on Earnings Growth, Pipeline Progress, and Market Catalysts
Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...
BioPharma Dive
6d
Sanofi readies to meet US demand for RSV antibody
With a new production line, Sanofi aims to keep it and partner AstraZeneca’s drug Beyfortus in fully supply this RSV season.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Sanofi
RSV
United States
Human respiratory syncytial virus
Feedback